Syncom Formulation Corporate Filings & Announcements

Latest corporate announcements and filings from Syncom Formulation on BSE

Search Inside the pdf :

Syncom Formulation (India) Ltd.

03 Jan 2026

13.90

-1.91%

Company Update

Syncom Formulations India Ltd-$ - 524470 - Pursuant To Regulation 30 Read With Schedule III Part …

BSE India

Pursuant to Regulation 30 read with Schedule lll Part A of SEBI (LODR) Regulations, 2015 for the demand raised under section 74(5) of CGST Act, 2017 for Ineligible Input Tax Credits also section 122 of CGST Act, 2017 for penalty.

pdf

Syncom Formulation (India) Ltd.

26 Dec 2025

13.90

-1.91%

SAST

Syncom Formulations India Ltd-$ - 524470 - Closure of Trading Window

BSE India

Closure of Trading Window for the quarter ending 31.12.2025 pursuant to SEBI(PIT)REG, 2015

pdf

Syncom Formulation (India) Ltd.

22 Nov 2025

13.90

-1.91%

Company Update

Syncom Formulations India Ltd-$ - 524470 - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015 …

BSE India

we hereby inform the Exchange that the company''s bid for the acquisition of a commercial property has been accepted by HDFC Bank Ltd, which is material in nature.

pdf

Syncom Formulation (India) Ltd.

13 Nov 2025

13.90

-1.91%

Company Update

Syncom Formulations India Ltd-$ - 524470 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Submission of press clipping related to extract of unaudited quarter/half year ended financial results for the quarter/half year ended on 30th September 2025

pdf

Syncom Formulation (India) Ltd.

12 Nov 2025

13.90

-1.91%

Result

Syncom Formulations India Ltd-$ - 524470 - Regulation 33(3) Of SEBI (LODR) Regulations, 2015 - Submission …

BSE India

Submission of Unaudited Standalone and consolidated Financial results for the Quarter ended 30.09.2025

pdf

Syncom Formulation (India) Ltd.

12 Nov 2025

13.90

-1.91%

Board Meeting

Syncom Formulations India Ltd-$ - 524470 - Board Meeting Outcome for Regulation 33(3) Of SEBI (LODR) …

BSE India

This is in continuation of our letter no. SYNCOM/SE/2025-26 dated 7th November, 2025 regarding intimation of Board meeting for consideration and approval of Standalone and Consolidated Un-Audited Financial Results for the Quarter/ Half Year ended 30th September, 2025.

pdf

Syncom Formulation (India) Ltd.

07 Nov 2025

13.90

-1.91%

Board Meeting

Syncom Formulations India Ltd-$ - 524470 - Board Meeting Intimation for Board Meeting Intimation

BSE India

Syncom Formulations India Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 ,inter alia, to consider and approve Corporate Announcement u/r 29(1)(a) of SEBI (LODR) Regulations, 2015 read with SEBI (PIT) Regulations, 2015 regarding intimation of holding the 3/2025-26 Board Meeting for consideration and approval of the Standalone and Consolidated Unaudited Financial Results along with Statement of Assets and Liabilities and Cash Flow for the quarter and half year ended on 30th September, 2025.

pdf